The ReKInDLE Study: A Phase 2 Trial of a New Quadruplet Therapy for R/R Multiple Myeloma

HealthDay interviews Benjamin Diamond, MD, Asst. Professor at the Miller School of Medicine at the University of Miami, about the ReKInDLE study, a phase 2 trial of iberdomide, carfilzomib, daratumumab and dexamethasone for relapsed/refractory multiple myeloma.